United States · Wires & real time · PR Newswire

Cystic Fibrosis Market Poised for Growth During the Forecast Period (2026-2036) as CFTR Modulators Transform Treatment Landscape | DelveInsight

Published by PR Newswire · United States 1 h ago

DelveInsight's analysis predicts significant growth in the cystic fibrosis market from 2026 to 2036, driven by the launch of emerging therapies such as Lonodelestat (Spexis),…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Associated Press (Business)

Here’s why Rubio is visiting a small Indian city home to world’s largest oil-refining complex

Business Wire

Accenture, Dragos and SANS Institute Launch Foundation to Strengthen Cyber Defenses for Under-Resourced U.S. Utilities

Dow Jones Newswires

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires